Lipedema and PCOS: Why These Two Conditions Often Appear Together

If you have been diagnosed with polycystic ovary syndrome (PCOS) and have also noticed disproportionate, painful fat accumulation in your lower body that does not respond to diet or exercise, you are not alone — and there may be more than one thing going on.

Lipedema and PCOS are distinct conditions, but they are not unrelated. Both involve hormonal disruption, both primarily affect women, and both can produce lower-body weight changes that are frequently misattributed to simple lifestyle factors. The co-occurrence is common enough that any woman with PCOS who also has lower-body fat distribution that behaves unusually should have lipedema specifically evaluated — and vice versa.

What is PCOS?

PCOS is one of the most common hormonal conditions affecting women of reproductive age, with an estimated prevalence of 8–13% worldwide, according to the World Health Organization (2023). It is characterised by:

• Ovulatory dysfunction — irregular, absent, or unpredictable menstrual cycles
• Androgen excess — elevated testosterone and related androgens, producing symptoms such as acne, hirsutism, and hair thinning
• Polycystic ovarian morphology — multiple small follicles visible on ultrasound (though this criterion alone is not sufficient for diagnosis)

PCOS is also strongly associated with insulin resistance, which is present in approximately 50–70% of women with PCOS regardless of body weight. This metabolic component has downstream effects on fat distribution, inflammation, and hormone balance that overlap significantly with lipedema's pathophysiology.

What is lipedema?

Lipedema is a chronic disorder of abnormal adipose tissue distribution, almost exclusively affecting women. Fat accumulates symmetrically in the hips, thighs, and lower legs — and sometimes the upper arms — in a pattern that is:

• Disproportionate to the upper body
• Painful and tender to pressure
• Associated with easy bruising
• Resistant to caloric restriction and exercise
• Typically triggered or worsened by hormonal events (puberty, pregnancy, perimenopause)

Lipedema affects an estimated 11% of women worldwide (Phlebology, 2019), though underdiagnosis remains significant.

Why the two conditions co-occur

The relationship between PCOS and lipedema is not fully characterised in the research literature, but several biological pathways plausibly explain the association.

Estrogen and adipose tissue behaviour

Both conditions are sensitive to hormonal fluctuations, particularly involving estrogen and progesterone. Lipedema fat tissue has been shown to have an abnormal hormonal response — the distribution pattern worsens at puberty, pregnancy, and menopause, all events driven by hormonal shifts. PCOS involves chronic hormonal imbalance, which may continuously create the hormonal environment that amplifies lipedema tissue behaviour.

Insulin resistance

Insulin resistance, prominent in PCOS, promotes fat deposition and may impair the normal regulation of adipose tissue distribution. Some researchers have proposed that insulin resistance creates a metabolic environment that facilitates the development or worsening of lipedema tissue. A low-carbohydrate or ketogenic dietary approach — which directly targets insulin resistance — is reported by some women with lipedema to reduce symptoms, which may partly explain why this approach also benefits some women with PCOS.

Inflammation

Both PCOS and lipedema involve elevated systemic and local inflammation. Pro-inflammatory cytokines are elevated in PCOS adipose tissue and in lipedema tissue independently. When both conditions are present, the inflammatory burden may be additive.

Hormonal fat distribution

PCOS-related androgen excess alters fat distribution toward the abdomen. Lipedema fat distribution concentrates in the lower body. When both conditions are present, a woman may experience abdominal fat accumulation (PCOS-driven) alongside disproportionate lower-body tissue (lipedema-driven), which makes clinical differentiation more complex.

How to tell them apart — and when both are present

The overlap in presentation creates diagnostic confusion. This table summarises the key distinguishing features:

Feature	PCOS	Lipedema	Both
Hormonal disruption	Yes — androgen excess, cycle irregularity	Yes — estrogen sensitivity, hormonal onset	Both present
Fat distribution	Abdominal / central	Lower body, symmetrical	Can appear mixed
Insulin resistance	Common (50–70%)	Possible but not defining	May compound each other
Pain and tenderness in fat	Not characteristic	Defining feature	Lipedema contribution
Bruising without cause	Not characteristic	Very common	Lipedema contribution
Cycle irregularity	Defining	Not defining, but symptoms often cycle-correlated	PCOS contribution
Androgen symptoms (acne, hirsutism)	Common	Not characteristic	PCOS contribution
Response to weight loss	Typically proportional	Lower body unaffected	Lipedema contribution

If you have PCOS and have noticed that your lower body distribution does not respond to weight loss in the way your upper body does — especially if the tissue is painful and bruises easily — lipedema warrants specific evaluation.

Implications for management

Having both conditions simultaneously affects the management approach in several ways.

Diet and metabolic management

The dietary approaches most supported for PCOS — lower refined carbohydrate intake, improved insulin sensitivity, reduced processed sugar — are also consistent with the anti-inflammatory approach used in lipedema management. A low-glycaemic or ketogenic diet can address both simultaneously, though it requires individualised guidance because both conditions respond differently across individuals.

Hormonal treatment

Hormonal therapies for PCOS (the oral contraceptive pill, progesterone-only methods, or anti-androgens like spironolactone) may affect lipedema symptoms in either direction. Some women find hormonal regulation improves their lipedema symptoms. Others find certain preparations worsen fluid retention and swelling. Tracking symptoms carefully during any hormonal treatment change is clinically important.

Cycle awareness

Both conditions produce symptoms that vary across the menstrual cycle. For lipedema, the luteal phase (days 15–28) is most commonly associated with symptom worsening — swelling, heaviness, and pain often increase before menstruation. For PCOS, cycle irregularity means this pattern may be less predictable. Tracking both symptoms and cycle phase systematically is the only way to identify your personal pattern.

Exercise

Low-impact, non-inflammatory exercise benefits both conditions. High-intensity training can worsen lipedema symptoms through inflammation while potentially being beneficial for PCOS-related insulin resistance. Finding the right intensity and form of movement — and observing how your body responds — requires individual testing over time.

Getting the right diagnosis

If you have PCOS and suspect you may also have lipedema, you will likely need input from two types of specialists:

• A gynaecologist or endocrinologist with experience managing PCOS
• A vascular surgeon, phlebologist, or certified lymphedema therapist familiar with lipedema

Most general practitioners do not have specific expertise in either condition and may treat the combination as generalised weight management. If your lower-body fat is painful, does not reduce with dieting, and is symmetrically distributed in a way that stops at the ankle, pursue specialist evaluation rather than accepting a generic response.

See how to find a lipedema specialist for guidance on identifying the right clinician.

Tracking what matters when you have both conditions

When two conditions interact, tracking becomes essential — not optional. The variables that matter most for PCOS (cycle regularity, insulin response to diet, androgen symptoms) overlap with but do not replace the variables that matter most for lipedema (pain, swelling, tenderness, compression use, dietary correlation).

A daily log that captures pain, swelling, heaviness, cycle phase, dietary patterns, and conservative care allows you to see which symptoms are cycle-correlated (suggesting hormonal/PCOS influence) and which are more constant or diet-correlated (suggesting lipedema inflammation). This distinction matters both for your own understanding and for what you bring to specialist appointments.

Lipedema IQ was built to capture exactly these variables — in a structure that makes the patterns visible over weeks, not just in retrospect. If you are managing multiple hormonal conditions, having a single organised record that reflects the full picture is more useful than multiple separate notes.

Frequently asked questions

Does having PCOS cause lipedema? PCOS does not cause lipedema. Both conditions can occur independently. However, they share hormonal and metabolic risk factors that may make co-occurrence more likely than chance. The exact relationship is not yet fully characterised in research.

Can lipedema be mistaken for PCOS weight gain? Yes. Both can produce lower-body changes that clinicians may attribute to PCOS-related metabolic dysfunction. If weight management approaches recommended for PCOS are not affecting your lower body, this is worth raising specifically with your provider.

Does treating PCOS improve lipedema? Indirectly, in some cases. Managing insulin resistance through diet, medication (such as metformin), or hormonal therapy may reduce one of the potential amplifying factors for lipedema. But lipedema tissue itself does not resolve with PCOS treatment. Separate management for lipedema — compression, MLD, anti-inflammatory approach — remains necessary.

What tests confirm PCOS versus lipedema? PCOS is confirmed through blood tests (LH/FSH ratio, testosterone, fasting insulin, ultrasound). Lipedema is diagnosed clinically — by physical examination and symptom history — because no definitive test exists. Both assessments require different specialists and different evaluation criteria.